Management of Elevated White Blood Cell Count

Initial Risk Stratification

The American Society of Hematology recommends determining urgency based on absolute white blood cell count, with WBC >100,000/μL considered a medical emergency requiring immediate hydration and hydroxyurea 1, 2
A white blood cell count of ≥14,000/μL or left shift present warrants systematic evaluation for infection or hematologic malignancy, with a likelihood ratio of 3.7 for bacterial infection 1, 3

The National Comprehensive Cancer Network recommends obtaining a complete blood count with differential and peripheral smear to assess for blast cells, band forms, cell maturity, toxic granulations, and eosinophilia 1, 3
A comprehensive metabolic panel, including electrolytes, uric acid, and LDH, should be obtained to assess tumor lysis syndrome risk 2
Blood cultures should be obtained before antibiotics if infection is suspected, even without fever 3

The European Society for Medical Oncology recommends initiating cytoreduction protocol immediately, including aggressive IV hydration at 2.5-3 liters/m²/day and hydroxyurea 50-60 mg/kg/day 1, 4
Rasburicase or allopurinol should be used for tumor lysis syndrome prophylaxis, with rasburicase preferred for high tumor burden and elevated baseline uric acid 2
Leukapheresis or exchange transfusion may be necessary for organ-threatening emergencies, achieving 30-80% white blood cell reduction within hours 4

The Infectious Diseases Society of America recommends initiating empiric broad-spectrum antimicrobials based on likely source without waiting for culture results 1
Urinalysis and urine culture should be obtained if a urinary source is suspected 3
Prophylactic fluoroquinolones may be considered if prolonged profound granulocytopenia is expected 1

The American College of Physicians recommends starting standard induction chemotherapy with cytarabine and anthracycline for non-promyelocytic acute myeloid leukemia 1
For acute promyelocytic leukemia, all-trans retinoic acid (ATRA) should be initiated immediately, and chemotherapy started without delay if white blood cell count >10 × 10⁹/L, even if molecular results are pending 1

The American Society of Clinical Oncology recommends platelet transfusion if counts ≤10×10⁹/L to prevent bleeding 1
Posaconazole may be used for antifungal prophylaxis in high-risk patients, as it is superior to fluconazole for decreasing fungal infections 1
Growth factors (GM-CSF, G-CSF) should be avoided after induction chemotherapy, as they confound bone marrow interpretation, and discontinued at least 7 days before remission assessment 1